"AMBS" - "The next Amgen in its infancy for less than a nickle." Uplisting to the NASDAQ planned for 2014. Zack's Analyst - "BUY" Rating - Price target Offers 400% Upside http://seekingalpha.com/article/1848901-amarantus-fundamentals-are-improving?source=yahoo Amarantus Relocates Headquarters to Janssen Labs @QB3 Incubator in San Francisco http://finance.yahoo.com/news/amarantus-relocates-headquarters-janssen-labs-153100892.html